| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/12/1992 | EP0498784A2 Inhibitors of retroviral protease |
| 08/12/1992 | EP0498771A2 MSH peptide derivatives |
| 08/12/1992 | EP0498767A2 Chimeric antiidiotypic monoclonal antibodies |
| 08/12/1992 | EP0498728A1 Glycyl-serine amides and cosmetic, pharmaceutical or alimentary compositions containting them |
| 08/12/1992 | EP0498680A1 New beta-amino-alpha-hydroxycarboxylic acids and their use |
| 08/12/1992 | EP0498658A2 Composition for inducing humoral anergy to an immunogen |
| 08/12/1992 | EP0498532A1 Necrotic tissue debridement powder composition containing a proteolytic enzyme |
| 08/12/1992 | EP0498508A1 Factor IIa inhibitors |
| 08/12/1992 | EP0498471A2 Liposomes comprising a guanidino aminoglycoside |
| 08/12/1992 | EP0498470A2 An injectable pharmaceutical composition for the protection of tissue damaged by ischemia |
| 08/12/1992 | EP0498361A2 Combination of an angiotensin II antagonist or renin inhibitor with a neutral endopeptidase inhibitor |
| 08/12/1992 | EP0498268A2 5-Oxo-L-proline derivatives and pharmaceutical use thereof |
| 08/12/1992 | EP0498133A1 Process for the purification of human albumin |
| 08/12/1992 | EP0498069A2 New use of peptide derivative |
| 08/12/1992 | EP0497950A1 Mutation of hrv2 2a |
| 08/12/1992 | EP0497929A1 Composition for stabilizing blood plasma during pasteurization. |
| 08/12/1992 | EP0497928A1 Yeast-derived epidermal growth factor/urogastrone-like products |
| 08/12/1992 | EP0497922A1 Infective protein delivery system |
| 08/12/1992 | EP0497915A1 hPTH (1-37) FRAGMENT, ITS PRODUCTION, DRUG CONTAINING IT AND ITS USE. |
| 08/12/1992 | EP0497911A1 Recombinant production of lactoperoxidase |
| 08/12/1992 | EP0497904A1 Compositions containing plant-produced glycopolypeptide multimers and methods for their production |
| 08/12/1992 | EP0497867A1 Polypeptide inhibitors of gamma interferon |
| 08/12/1992 | EP0497866A1 Gastrin releasing peptide receptor |
| 08/12/1992 | EP0497835A1 Method for treating hiv and other retroviruses and compounds useful therefor |
| 08/12/1992 | EP0497833A1 C1 inhibitor muteins and uses thereof |
| 08/12/1992 | EP0497771A1 Dithiochrome, an insulin-binding molecule with glucose metabolism-related pharmaceutical utility |
| 08/12/1992 | EP0494256A4 Evaluative means for detecting inflammatory reactivity and for predicting response to stress |
| 08/12/1992 | EP0489062A4 Bone-specific protein |
| 08/12/1992 | EP0456766A4 Type oc platelet-derived growth factor receptor gene |
| 08/12/1992 | EP0160699B1 Production of heterodimeric human fertlity hormones |
| 08/12/1992 | CN1063507A Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
| 08/12/1992 | CN1017799B Glycine compounds and process for preparing them |
| 08/12/1992 | CA2060741A1 Gm-csf inhibiting oligopeptides |
| 08/12/1992 | CA2060699A1 Gm-csf inhibiting oligopeptides |
| 08/12/1992 | CA2059842A1 Ige-receptor-antibodies |
| 08/11/1992 | US5138061 For introducing thioamide bonds into growing peptides |
| 08/11/1992 | US5138036 Inhibits growth of leukemia |
| 08/11/1992 | US5138035 Enzyme inhibitors |
| 08/11/1992 | US5138034 Freezing, ethanol extraction, ion exchanging, chromatography |
| 08/11/1992 | US5138033 Marek's disease herpesvirus glycoproteins GE |
| 08/11/1992 | US5137900 Antagonists of cholecystokinin and gastrin, antabiotic, analgasic, antiulcer, antitumor and for treatment of gastro intestinal and central nervous system disorders |
| 08/11/1992 | US5137874 For parenteral administration |
| 08/11/1992 | US5137873 Substance p and tachykinin agonists for treatment of alzheimer's disease |
| 08/11/1992 | US5137872 Growth hormone-releasing factor analogs |
| 08/11/1992 | US5137871 Treatment to reduce edema for brain and musculature injuries |
| 08/11/1992 | US5137820 Superoxide dismutase derivatives, a method of producing the same and medicinal uses of the same |
| 08/11/1992 | US5137805 Method of diagnosing stress condition by specific binding of human heat shock factor |
| 08/11/1992 | US5137734 Administering to stimulate wound healing and neovascularization |
| 08/11/1992 | US5137725 Dispersion of lipidic spherules |
| 08/11/1992 | US5137720 Hybrid interferon polypeptide and muramylpeptide; synergistic |
| 08/11/1992 | CA1306212C Insulin analogues and process for their preparation |
| 08/11/1992 | CA1306210C Bacillus thuringiensis gene encoding a coleopteran-active toxin |
| 08/11/1992 | CA1306194C Use of amphipathic molecules for radio-imaging and therapy with conjugates of monoclonal or polyclonal antibodies |
| 08/10/1992 | WO1992013539A1 Ovulation-preventing agent for hormonal contraception |
| 08/10/1992 | CA2060856A1 Amino acid derivatives |
| 08/09/1992 | WO1992013946A1 Htlv-i and htlv-ii peptide antigens and methods |
| 08/09/1992 | WO1992013558A1 A composition for inducing humoral anergy |
| 08/09/1992 | CA2060844A1 Beta-amino-alpha-hydroxycarboxylic acids and their use |
| 08/08/1992 | CA2060785A1 Inhibitors of retroviral protease |
| 08/07/1992 | CA2060626A1 Chimeric antiidiotypic monoclonal antibodies |
| 08/07/1992 | CA2060615A1 Use of dipeptidic amides derived from glycyl-serine as surfactants or hydrating agents, especially in cosmetic, pharmaceutical or food compositions; new dipeptidic amides |
| 08/06/1992 | WO1992013095A1 Methods for treating tumor necrosis factor mediated diseases |
| 08/06/1992 | WO1992013093A1 Antigen recognized by patients with antibody associated cerebellar degeneration, dna encoding same and uses thereof |
| 08/06/1992 | WO1992013092A1 Methods of transcriptionally modulating expression of hematopoietic growth factor genes |
| 08/06/1992 | WO1992013091A1 Methods of transcriptionally modulating expression of oncogenes and tumor suppressor genes |
| 08/06/1992 | WO1992013090A1 Trans-splicing ribozymes |
| 08/06/1992 | WO1992013089A1 Cell ablation using trans-splicing ribozymes |
| 08/06/1992 | WO1992013083A1 Nucleic acid encoding insulin receptor substrate-1 (irs-1), irs-1 protein, diseases, therapy associated with the metabolism of irs-1 |
| 08/06/1992 | WO1992013078A2 Pasteurella haemolytica glycoprotease gene and the purified enzyme |
| 08/06/1992 | WO1992013075A1 Megakaryocyte stimulating factors |
| 08/06/1992 | WO1992013074A1 CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN (CRF-bp) |
| 08/06/1992 | WO1992013073A1 Pdgf-b analogues |
| 08/06/1992 | WO1992013072A2 Process for the synthesis and purification of human ciliary neuronotrophic factor (cntf) from escherichia coli |
| 08/06/1992 | WO1992013069A1 Test and model for alzheimer's disease |
| 08/06/1992 | WO1992013003A1 Macroscopically oriented cell adhesion protein for wound treatment |
| 08/06/1992 | WO1992013001A1 A RECEPTOR TYROSINE KINASE TARGET PROTEIN cDNA CLONING METHOD AND hGRB PROTEINS |
| 08/06/1992 | WO1992013000A1 Novel thyroid antigen |
| 08/06/1992 | WO1992012997A1 Human galanin |
| 08/06/1992 | WO1992012996A2 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 08/06/1992 | WO1992012994A1 Mixed specificity fusion proteins |
| 08/06/1992 | WO1992012960A2 Derivatives of dicarboxylic acids having six to twelve carbon atoms and use of these derivatives and dicarboxylic acids alone in the preparation of pharmaceutical compositions for enteral and parenteral nutrition |
| 08/06/1992 | WO1992012952A1 Malic acid derivatives and compositions for the treatment of psoriasis |
| 08/06/1992 | WO1992012739A1 Depot formulations |
| 08/06/1992 | WO1992012734A1 Anti-growth factor antibodies in the treatment of vascular stenosis |
| 08/06/1992 | WO1992012733A1 Method for the elimination of the 'boar odour' from meat |
| 08/06/1992 | WO1992012730A1 A method and a system for enhanced in vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion, and the use of said agents for said purpose |
| 08/06/1992 | WO1992012726A1 Use of interleukin-10 in adoptive immunotherapy of cancer |
| 08/06/1992 | WO1992012725A1 Treatment of neoplastic disease with interleukin-10 |
| 08/06/1992 | WO1992012724A1 Method of preventing and treating insulin dependent diabetes mellitus |
| 08/06/1992 | WO1992012717A2 A composition containing a tetracycline and use for inhibiting angiogenesis |
| 08/06/1992 | WO1992012635A1 Methods of transcriptionally modulating gene expression of viral genes and other genes |
| 08/06/1992 | WO1992008740A3 Receptor recognition factor and methods of use thereof |
| 08/06/1992 | CA2372251A1 Test and model for alzheimer's disease |
| 08/06/1992 | CA2101781A1 Pasteurella haemolytica glycoprotease gene and the purified enzyme |
| 08/06/1992 | CA2101065A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 08/06/1992 | CA2100553A1 Treatment of neoplastic disease with interleukin-10 |
| 08/06/1992 | CA2100068A1 Trans-splicing ribozymes |
| 08/06/1992 | CA2097424A1 Corticotropin releasing factor binding protein (crf-bp) |
| 08/05/1992 | WO1992013877A1 Factor iia inhibitors |
| 08/05/1992 | EP0497525A2 Pneumococcal polysaccharide conjugate vaccine |